Form 4 for DGX Quest Diagnostics
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001022079-24-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-01 | 2024-02-28+ | DGX | Doherty Catherine T. | EVP, Regional Businesses | S - Sale | $126.45 | -6,744 | 68.4K | -9% | -$852.8K |
| M | 2024-03-01 | 2024-02-28 | DGX | Doherty Catherine T. | EVP, Regional Businesses | F - Tax | $126.36 | -1,201 | 75.7K | -2% | -$151.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | S | D | 5,557 | $126.57 | 69,599 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-28 | F | D | 557 | $126.36 | 75,156 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. |
| 3 | Common | Common Stock | 2024-02-28 | F | D | 644 | $126.36 | 75,713 | D | — | — | (F1) Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. |
| 4 | Common | Common Stock | 2024-02-29 | S | D | 1,187 | $125.88 | 68,412 | D | — | — |